Erratum to: The calcium-sensing receptor and 25-hydroxyvitamin D-1α-hydroxylase interact to modulate skeletal growth and bone turnover (Journal of Bone and Mineral Research, 25, 7, (1627-1636), 10.1002/jbmr.58);The calcium-sensing receptor and 25-hydroxyvitamin D-1α-hydroxylase interact to modulate skeletal growth and bone turnover

Journal of Bone and Mineral Research

Volumn 25, Issue 7, 2010, Pages 1627-1636

  Richard, Christian ^a   Huo, Rujuan ^a   Samadfam, Rana ^a   Bolivar, Isabel ^a   Miao, Dengshun ^b   Brown, Edward M ^c   Hendy, Geoffrey N ^a   Goltzman, David ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NANJING MEDICAL UNIVERSITY   (China)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bone resorption; Calcium sensing receptor; Osteomalacia; Parathyroid hormone action; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D 1ALPHA HYDROXYLASE; CALCIUM; CALCIUM SENSING RECEPTOR; LACTOSE; OXYGENASE; PARATHYROID HORMONE; PHOSPHORUS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE GROWTH; BONE MINERALIZATION; BONE TURNOVER; CALCIUM INTAKE; CONTROLLED STUDY; DIETARY INTAKE; EMBRYO; GROWTH PLATE; GROWTH RETARDATION; HYPOCALCEMIA; MOUSE; NONHUMAN; OSTEOBLAST; TRABECULAR BONE;

EID: 77954744645     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.3535     Document Type: Erratum

References (39)

1. 2+-sensing receptor from bovine parathyroid. Nature. 1993;366:575-580.
2. 2+-sensing receptor gene mutation. Nat Genet. 1994;8:303-307.
3. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell. 1993;75:1297-1303.
4. Ho C, Conner DA, Pollak MR, et al. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet. 1995;11:389-394.
5. Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev. 1998;78:1193-1231. (Pubitemid 28491953)
6. Haussler MR, Whitfield GK, Haussler CA, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998;13:325-349.
7. St. Arnaud R, Messerlian S, Moir JM, Omdahl JL, Glorieux FH. The 25-hydroxyvitamin D 1α-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J Bone Miner Res. 1997;12:1552-1559. (Pubitemid 27422355)
8. Marx SJ, Spiegel AM, Brown EM, et al. A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab. 1978;47:1303-1310.
9. Panda DK, Miao D, Tremblay ML, et al. Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: evidence for skeletal, reproductive and immune dysfunction. Proc Natl Acad Sci USA. 2001;98:7498-7503. (Pubitemid 32567977)
10. Chang W, Tu C, Chen TH, et al. Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology. 1999;140:5883-5893. (Pubitemid 30645377)
11. 2+-sensing receptor promotes loss of cancellous bone. Endocrinology. 2007;148:3156-3163.
12. Chang W, Tu C, Chen TH, Bikle D, Shoback D. The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development. Sci Signal. 2008;1: ra1.
13. Tu Q, Pi M, Karsenty G, Simpson L, Liu S, Quarles LD. Rescue of the skeletal phenotype in CasR-deficient mice by transfer onto the Gcm2 null background. J Clin Invest. 2003;111:1029-1037. (Pubitemid 36397479)
14. Kos CH, Karaplis AC, Peng JB, et al. The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone. J Clin Invest. 2003;111:1021-1028.
15. Panda DK, Miao D, Bolivar I, et al. Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem. 2004;279:16754-16766. (Pubitemid 38509378)
16. Samadfam R, Xia Q, Goltzman D. Co-treatment of PTH with osteoprotegerin or alendronate increases its anabolic effect on the skeleton of oophorectomized mice. J Bone Miner Res. 2007;22:55-63. (Pubitemid 46032597)
17. Miao D, He B, Jiang Y, et al. Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest. 2005;115:2402-2411.
18. Lopez-De Leon A, Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem. 1985;33:737-743.
19. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987;2:595-561.
20. Garner SC, Pi M, Tu Q, Quarles LD. Rickets in cation-sensing receptor-deficient mice: An unexpected skeletal phenotype. Endocrinology. 2001;142:3996-4005.
21. Chang W, Tu C, Bajra R, et al. Calcium sensing in cultured chondrogenic RCJ3.1C5.18 cells. Endocrinology. 1999;140:1911-1919.
22. Chang W, Tu C, Pratt S, Chen TH, Shoback D. Extracellular Ca(2+)-sensing receptors modulate matrix production and mineralization in chondrogenic RCJ3.1C5.18 cells. Endocrinology. 2002;143:1467-1474.
23. Rodriguez L, Cheng Z, Chen TH, Tu C, Chang W. Extracellular calcium and parathyroid hormone-related peptide signaling modulate the pace of growth plate chondrocyte differentiation. Endocrinology. 2005;146:4597-4608.
24. Murshed M, Harmey D, Millán JL, McKee MD, Karsenty G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev. 2005;19:1093-1104.
25. Sabbagh Y, Carpenter TO, Demay MB. Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. Proc Natl Acad Sci U S A. 2005;102:9637-9642.
26. Rodriguez L, Tu C, Cheng Z, et al. Expression and functional assessment of an alternatively spliced extracellular Ca2+-sensing receptor in growth plate chondrocytes. Endocrinology. 2005;146:5294-5303.
27. Oda Y, Tu CL, Chang W, et al. The calcium sensing receptor and its alternatively spliced form in murine epidermal differentiation. J Biol Chem. 2000;275:1183-1190.
28. Imanishi Y, Hosokawa Y, Yoshimoto K, et al. Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest. 2001;107:1093-1102.
29. Parisien M, Silverberg S, Shane E, et al. The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab. 1990;70:930-938.
30. Huang C, Miller RT. Regulation of renal ion transport by the calcium-sensing receptor: an update. Curr Opin Nephrol Hypertens. 2007;16:437-443. (Pubitemid 47254694)
31. Pi M, Faber P, Ekema G, et al. Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J Biol Chem. 2005;280:40201-40209.
32. Pi M, Chen L, Huang MZ, et al. GPRC6A Null Mice Exhibit Osteopenia, Feminization and Metabolic Syndrome. PLoS ONE. 2008;3:e3858.
33. Wellendorph P, Johansen L, Jensen A, et al. No evidence for a bone phenotype in GPRC6A knockout mice under normal physiological conditions. J Mol Endocrinol. 2009;42:215-223.
34. Dardenne O, Prud'homme J, Hacking SA, Glorieux FH, St-Arnaud R. Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1). Bone. 2003;32:332-340.
35. Amling M, Priemel M, Holzmann T, et al. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology. 1999;140:4982-4987.
36. Bar-Shavit Z, Kahn AJ, Teitelbaum SL. Defective binding of macrophages to bone in rodent osteomalacia and vitamin D deficiency: in vitro evidence for a cellular defect and altered saccharides in the bone matrix. J Clin Invest. 1983;72:526-534. (Pubitemid 13051312)
37. Hollberg K, Marsell R, Norgård M, Larsson T, Jonsson KB, Andersson G. Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice. Bone. 2008;42:1111-1121.
38. Suzumoto R, Takami M, Sasaki T. Differentiation and function of osteoclasts cultured on bone and cartilage. J Electron Microsc (Tokyo). 2005;54:529-540.
39. Mentaverri R, Yano S, Chattopadhyay N, et al. The calcium sensing receptor is directly involved in both Osteoclast differentiation and apoptosis. FASEB J. 2006;20:2562-2564.